IM Cannabis Corp. (IMCC)
NASDAQ: IMCC · Real-Time Price · USD
0.8777
-0.0470 (-5.08%)
At close: Oct 23, 2026, 4:00 PM EDT
0.8692
-0.0085 (-0.97%)
After-hours: Oct 23, 2026, 7:31 PM EDT

IM Cannabis Revenue

IM Cannabis had revenue of 7.59M CAD in the quarter ending June 30, 2026, a decrease of -40.23%. This brings the company's total for the last twelve months to 45.80M, down -12.61% year-over-year. In the year 2025, IM Cannabis had annual revenue of 54.73M with 1.30% growth. That makes IM Cannabis the 30,896th largest company in the world by revenue and 4,078th in the United States.

Revenue (ttm)
45.80M CAD
Revenue Growth
-12.61%
P/S Ratio
0.04
Revenue / Employee
1,040,977 CAD
Employees
44
Market Cap
1.45M USD

Revenue Chart

* This company reports financials in CAD.

Revenue by Geography

  • Germany 36.35M 66.4%
  • Israel 18.38M 33.6%
Fiscal year ended Dec 31, 2025 See the full IM Cannabis breakdown

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 202554.73M700.00K1.30%
Dec 31, 202454.03M5.23M10.71%
Dec 31, 202348.80M-5.53M-10.18%
Dec 31, 202254.34M20.28M59.56%
Dec 31, 202134.05M18.16M114.30%
Dec 31, 202015.89M6.82M75.12%
Dec 31, 20199.07M3.88M74.60%
Dec 31, 20185.20M--

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. It does not take any expenses into account and is therefore different from profits.

Related Stocks

Company NameRevenue
Biofrontera46.18M
Sunshine Biopharma35.35M
Sonoma Pharmaceuticals21.92M
cbdMD20.93M
InMed Pharmaceuticals4.94M
Akanda662.47K
Gelteq314.70K
RedHill Biopharma286.00K
Revenue Rankings